Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.48%
#2 Ocean Protocol Ocean Protocol +21.53%
#3 Geodnet Geodnet +15.00%
#4 Audiera Audiera +11.80%
#5 Cysic Cysic +8.78%
#6 KUB Coin KUB Coin +8.63%
#7 Arowana Arowana +7.85%
#8 DexNet DexNet +7.78%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.66%
#10 Rollbit Coin Rollbit Coin +6.27%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Spago Nanomedical AB (publ) Spago Nanomedical AB (publ)

Spago Nanomedical AB (publ)

SPAGO
Clasificación en acciones #32285
Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to... Operating primarily in Sweden, Spago Nanomedical AB (publ) is dedicated to pioneering nanomedicines for both the diagnosis and treatment of cancer. The company is actively pursuing two key projects: the SpagoPix initiative, centered on SN132D, a gadolinium-free MRI contrast agent developed for imaging breast and pancreatic cancers; and the Tumorad project, which is advancing SN201, a radionuclide therapy intended for managing advanced and metastatic forms of cancer. Originally established as Spago Imaging AB (publ), the company adopted its current name, Spago Nanomedical AB (publ), in May 2014. Founded in 1999, its base of operations is situated in Lund, Sweden.
Precio por acción
$0.01317984
Última sincronización: 2026-08-17
Capitalización bursátil
$10.52M
Cambio (1 día)
-1.26%
Cambio (1 año)
-53.51%
País
SE
Comercio Spago Nanomedical AB (publ) (SPAGO)

Categoría

Healthcare
Ingresos de Spago Nanomedical AB (publ) (SPAGO)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Spago Nanomedical AB (publ), los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Spago Nanomedical AB (publ) desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR